-
RE: PSUR/PSUSA IRIS cases for non-CAP
Dear Caterina,
The question is not a general question, but on EMA IRIS Portal, how the case (or several cases) are opened for MRP and national procedures products.
How can EMA know to which ORG ID the contact person is affiliated to open the IRIS case ?
KR, Isha -
PSUR/PSUSA IRIS cases for non-CAP
Hi, can you please clarify under which ORG the PSUR/PSUSA case is meant to be opened for a non-CAP product, e.g. MRP with lots of RMS and CMS countries?
EMA information mentions ''For PSURs, contact is the person indicated in the PSUR submission form (and not in the cover letter)''
How can EMA know to which ORG ID the contact person is affiliated to open the IRIS case ?
thanks -
RE: RPI contact person
Dear Caterina,
the guidance document mentioned does not describe the concept of ''RPI contact person''. This is a new field requested during some submissions (e.g. paediatrics etc) and it should be clarified what it is referred to please. Can you please clarify. Thank you -
Information on clockstops/restarts for processes implemented in IRIS
At the Industry Stakeholder Platform meeting on the centralised procedure on 23/06/2025, LINK here, Information was shared on on clockstops/restarts for processes implemented in IRIS.
Is this already effective ? When will it be shared more ''officially'' with stakeholders. Will the IRIS guidance documents be updated accordingly, and by when ?
Thank you, Isha -
RPI contact person
What is the ''RPI contact person'', why is this requested, for which purpose, and how does it connect or not to a product contact person, and procedure contact person ?
-
RE: Transition of post-authorisation to IRIS overview + request to register in EMA IAM by Oct 2024
Dear All, I would like to follow-up on my previous questions please here above. BR, Isha -
RE: Transition of post-authorisation to IRIS overview + request to register in EMA IAM by Oct 2024
In addition,- It is not clear how/ from which time point the Contact person authorised for communication between the MAH and the competent authorities (referred to in sections 2.4.3 of the application form) has been assigned - as in some cases old contact person has recieved the EMA reminder email (although change contact form has been submitted previously and acknowledged by EMA) ?
- How those contact persons will be maintained ? change of contact in IRIS is flexible per submission. However, when we want to change a whole product contact person, do we still need to submit the contact change form via Service Now to EMA ?
- How will this person be or not be assigned to all previously related product procedures ?
- It is not clear how/ from which time point the Contact person authorised for communication between the MAH and the competent authorities (referred to in sections 2.4.3 of the application form) has been assigned - as in some cases old contact person has recieved the EMA reminder email (although change contact form has been submitted previously and acknowledged by EMA) ?
-
RE: Transition of post-authorisation to IRIS overview + request to register in EMA IAM by Oct 2024
Hello,
Do the following contact persons also need to be registered in EMA IRIS Portal , as some have already received reminders emails ? (That was actually not announced/ understood previously) ?
Can we keep the generic emails for those , as there is a higher risk of missing urgent/ legal emails (especially for QPPV and MAH Contact for CD) ?- Contact person at the MAH address (referred to in section 2.4.1 of the application form)
- Qualified person in the European Economic Area (EEA) for pharmacovigilance (referred to in section 2.4.4 of the application form).
- Scientific service of the MAH in the EEA as referred to in Article 98 of Directive 2001/83/EC (referred to in section 2.4.5 of the application form)
- Contact person in the EEA for product defects and recalls, as defined in Article 79 of Directive 2001/83/EC (referred to in section 2.5.1.1 of the application form)
Thank you.
-
PIP submission in EMA IRIS Portal, includes questions on submission pipeline ?
For an upcoming PIP submission in IRIS, the second category is 'Updated Information on RPI' and there are a series of questions on the submission pipeline - please attached screenshot.
Can you please explain how those questions are even related to RPI scientific data in IRIS, and why those questions are displayed as part of a PIP submission ?
We believe that this a total separate topic (submission predictability information) which should not be part of a PIP submission.
If you can please also clarify how this data is collected, tracked, used and communicated further within different stakeholders?
-
RE: Email for public enquiries for Orphan Designation
Hi, following my last question, I was wondering if the same could/will be applied for the email for public enquiries for Paediatrics Submissions?
1- Can we maintain that via IRIS as well ?
2- If not, how can we request update of emails displayed on EMA webpages ?
Thanks, Isha